Beatriz Dorado Avendaño

Mrs. Beatriz Dorado Avendaño

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
Maria InsenserMaria Insenser
Maria Insenser
LNLía Nattero-Chávez
Lía Nattero-Chávez
MLManuel Luque-Ramírez
Manuel Luque-Ramírez
SQSara de Lope Quiñones
Sara de Lope Quiñones
AQAlejandra Quintero-Tobar
Alejandra Quintero-Tobar
HEHéctor F. Escobar-Morreale
Héctor F. Escobar-Morreale
Sexual dimorphism influences cardiovascular outcomes in type 1 diabetes (T1D), with women facing a higher relative risk of macrovascular events compared to men, especially after menopause. This study hypothesizes that abnormalities in intermediate metabolism may be associated with cardiac autonomic neuropathy (CAN) in T1D. We aim to assess low molecular weight metabolites (LMWM) as markers of CAN in T1D, considering the effects of sexual dimorphism and age. In this cross-sectional study, we included 323 subjects with T1D (147 women and 176 men), with a mean age of 41 ± 13 years. A total of 44 women and 41 men were over 50 years old. CAN was assessed using Ewing’s tests, and serum metabolites were analyzed by proton nuclear magnetic resonance spectroscopy (1H-NMR). Patients with CAN had lower levels of valine, isoleucine, and threonine, and higher levels of lactate, compared to those without CAN. These differences persisted after adjusting for BMI and estimated glucose disposal rate (eGDR). In a logistic regression model (R² = 0.178, p < 0.001), the main determinants of CAN included isoleucine [Exp(β) = 0.972 (95% CI 0.952; 0.003)], age [Exp(β) = 1.031 (95% CI 1.010; 1.053)], A1c [Exp(β) = 1.361 (95% CI 1.058; 1.752)], and microangiopathy [Exp(β) = 2.560 (95% CI 1.372; 4.778)]. Sex influenced LMWM profiles, with over half of the metabolites differing between men and women. However, no interactions were found between CAN and sex, or between sex, age, and CAN, on metabolomics profiles. Our findings suggest an association between CAN and LMWM levels in T1D. The sexual dimorphism observed in amino acid metabolites was unaffected by the presence of CAN.

16 January 2025 in Metabolites
Verified
Journal Article
Open access
JSJhonatan Quiñones Silva
Jhonatan Quiñones Silva
MLManuel Luque-Ramírez
Manuel Luque-Ramírez
AFAntonio Carlos Michael Fernández
Antonio Carlos Michael Fernández
ATAlejandra Quintero Tobar
Alejandra Quintero Tobar
JQJhonatan Quiñones-Silva
Jhonatan Quiñones-Silva
LNLía Nattero-Chávez
Lía Nattero-Chávez
Introduction: This study aimed to evaluate whether glycoprotein and lipoprotein lipidomics profiles could enhance a clinical predictive model for carotid subclinical atherosclerosis in patients with type 1 diabetes (T1D). Additionally, we assessed the influence of cardiac autonomic neuropathy (CAN) on these predictive models. Methods: We conducted a cross-sectional study including 256 patients with T1D. Serum glycoprotein and lipoprotein lipidomics profiles were determined using 1H-NMR spectroscopy. Subclinical atherosclerosis was defined as carotid intima-media thickness (cIMT) ≥ 1.5 mm. CAN was identified using the Clarke score. Predictive models were built and their performance evaluated using receiver operating characteristic curves and cross-validation. Results: Subclinical atherosclerosis was detected in 32% of participants. Patients with both CAN and atherosclerosis were older, had a longer duration of diabetes, and were more likely to present with bilateral carotid disease. Clinical predictors such as age, duration of diabetes, and smoking status remained the strongest determinants of subclinical atherosclerosis [AUC = 0.88 (95%CI: 0.84–0.93)]. While glycoprotein and lipoprotein lipidomics profiles were associated with atherosclerosis, their inclusion in the clinical model did not significantly improve its diagnostic performance. Stratification by the presence of CAN revealed no impact on the model’s ability to predict subclinical atherosclerosis, underscoring its robustness across different risk subgroups. Conclusions: In a cohort of patients with T1D, subclinical atherosclerosis was strongly associated with traditional clinical risk factors. Advanced glycoprotein and lipoprotein lipidomics profiling, although associated with atherosclerosis, did not enhance the diagnostic accuracy of predictive models beyond clinical variables. The predictive model remained effective even in the presence of CAN, highlighting its reliability as a screening tool for identifying patients at risk of subclinical atherosclerosis.

20 July 2026 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
SQSara de Lope Quiñones
Sara de Lope Quiñones
MLManuel Luque-Ramírez
Manuel Luque-Ramírez
ATAlejandra Quintero Tobar
Alejandra Quintero Tobar
JCJosé Manuel Ruiz Cánovas
José Manuel Ruiz Cánovas
BABeatriz Dorado Avendaño
Beatriz Dorado Avendaño
LNLía Nattero-Chávez
Lía Nattero-Chávez